At present, NSCLC targets have been found, including epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), receptor tyrosine kinase ROS proto-oncogene 1 (ROS1) and Kirsten rat sarcoma virus oncogene (KRAS). The gene discussed is ALK; the disease is non-small cell lung carcinoma.